Cancer trial stops again after 2 more die

After more patient deaths, Juno Therapeutics announced Wednesday that it is voluntarily putting its “ROCKET” trial on hold for the second time this year. The patients enrolled in this Phase II trial are adults with relapsed or refractory B cell acute lymphoblastic leukemia, according to the biopharmaceutical company’s website.

Add Comment

*